A Phase I Study of Intravenous Recombinant Human IL-15 in Adults With Refractory Metastatic Malignant Melanoma and Metastatic Renal Cell Cancer
Clinical trial NCT01021059 · COMPLETED
Trial details
- NCT number
- NCT01021059
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-10
- Primary completion
- 2013-05-31
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.